GVR Report cover Immunofluorescence Assay Market Size, Share & Trends Report

Immunofluorescence Assay Market Size, Share & Trends Analysis Report By Type, By Product, By Application, By End-user, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453485
  • Number of Pages: 0
  • Format: Electronic (PDF)

Immunofluorescence assay is a technique used in virology for the detection of antibodies by its selective ability to react with the antigen present in the infected cell. For this purpose, fluorescent dyes are used. It is one of the applied techniques of light microscopy. The results obtained from the techniques of ELISA and MFIA are confirmed using immunofluorescence assay (IFA). The technique is applied to specific sections of tissues, cells, and cell line cultures. It is used to analyze small molecules, proteins, and glycan’s. The requirements of the assay are a reagent kit, antibodies specific to antigens, imaging equipment and assay kit.

The two classes of immunofluorescence are as follows -

  • Primary or direct immunofluorescence - Uses a single antibody linked to fluorophore detected using fluorescent microscopy. It is used to diagnose skin, and kidney diseases. Example- Lupus erythematosus disease diagnosis.

  • Secondary or indirect immunofluorescence - Uses two antibodies. In this, the primary antibody binds the target molecule, and secondary antibody is linked to a fluorophore. It is used to diagnose autoimmune blister skin diseases. Example- Pemphigoid gestationis disease diagnosis. 

Over the last few decades, the prevalence of chronic disease like Chron’s disease, HIV, and Alzheimer’s has increased globally. A growing awareness regarding the detection and cure to these diseases are some of the driving factors for market growth. The major applications of immunofluorescence assay are antibody detection, antigen detection in cell culture and membranes, biopsy, and detection of spread immune cells, for example- Secondary (Indirect) Immunofluorescence Assay is used for detection of anticell membrane associated DNA Abs in juvenile systemic lupus erythematosus. In this Anti-cmDNA Abs and antinuclear Abs were detected in the patient serum using immunofluorescence and ELISA. Recently in April 2021, a company named Euroimmum launched a compact immunofluorescence microscope EPML (EUROPattern Microscope Live). EPML is an automated instrument that captures the image within 2 seconds. It has a 20x high camera resolution. 

In IFA, the imaging equipment are used to detect the fluorescently linked antibodies in the sample. These instruments are quite advanced in features and expensive. So this can be a restraining factor for the market. Due to the increasing prevalence of the autoimmune diseases, chronic diseases, it takes maximum expenditure of healthcare and research services. The health insurance and growing medical reimbursement has a positive impact on the growing IFA market. However, increasing government funding in research services and surgical research services will boost the market. 

The immunofluorescence assay market is segmented into type, product, application, end-user and region. The type segment is further bifurcated into direct immunofluorescence, and indirect immunofluorescence. The product segment is divided into antibodies, reagents, kits, instruments, consumables and accessories. The application segment is based upon autoimmune diseases, neurological diseases, clinical research and diagnostics, cardiovascular diseases and cancer. The end -user segment is based upon pharmaceutical and biotechnology companies, contract research organizations, hospitals and diagnostic centers. The region segment is further segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The increasing prevalence of chronic diseases and infectious diseases is found to be the highest in North America and holds the highest share in the assay market. Moreover, the research is also supported through government funding and also developing the healthcare services that accelerates the market growth. Countries like India, China, and Brazil are expected to show a potential growth in the market in the near future. According to the research, India and China have a higher prevalence rate to diabetes that would boost the market. Middle East and Africa holds the least market share due to strict government policies, and poor economic development.

    Immunofluorescence Assay Market Segmentation 




Direct immunofluorescence (Primary), Indirect immunofluorescence (Secondary)


Antibodies, reagents, kits, instruments, consumables and accessories


Autoimmune Diseases, Neurological Diseases, Clinical Research and Diagnostics, Cardiovascular Diseases, Cancer

End user

Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Centers


North America (U.S., Canada),Europe (Germany, France, Italy, Spain, UK),Asia Pacific (Japan, China, India, South Korea, Australia),Latin America (Mexico, Brazil, Argentina),Middle East & Africa (Saudi Arabia, South Africa, UAE)


Major companies operating in the IFA market include Thermo Fisher Scientific Inc., MaxVision Biosciences Inc., Olympus Corporation, AESKU GROUP GmbH, Danaher Corporation, Bio-Rad Laboratories Inc., Merck KGaA, Bruker Corporation, Sino Biological Inc., Enzo Biochem Inc., Dikinson and Company, Cell Signaling Technology Inc., Bio Tek Instruments, Inc., Zyagen, BioLegend Inc. among others.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon